Âé¶¹´«Ã½

Data

News

Optimising electronic prescribing and medicine administration (EPMA) systems – patient safety spotlight

Safe and effective dose management in EPMA systems varies significantly across the UK, posing a significant risk of harm to infants, children and young people. This blog summarises an Âé¶¹´«Ã½/NPPG Joint Medicines Committee position statement that outlines the key factors leading to variation in these ...
Document

Safe and effective dose management in electronic prescribing and medicines administration systems

This position statement is made on behalf of the Joint Âé¶¹´«Ã½ and NPPG Medicines Committee. The Medicines Committee is a collaborative standing committee with joint membership between Royal College of Paediatrics and Child Health (Âé¶¹´«Ã½) and Neonatal and Paediatric Pharmacy Group (NPPG).
Basic page

National Paediatric Diabetes Audit (NPDA) - transparency and open data

This page provides access to NPDA transparency and governance resources, including NPDA privacy statements, NPDA data protection impact assessments, the Âé¶¹´«Ã½ data protection policy and detailed notes on data analysis, cleaning and validation. These documents set out how NPDA data is managed, protec...